Knowledge & Courses for “cyclosporiasis”
Google Trends · Automated AI Business Plan

Knowledge & Courses for “cyclosporiasis”

Lightweight courses and a community around a fast-growing topic, sold as paid knowledge.

Source keyword cyclosporiasis volume 10,000 · growth +200% · persistence: Recurring (2 observations over 2 days) · intent: Informational (6/10) · category Health · region US · collected 07/08/2026, 08:16 AM
CycloAlert AI
9.8%
Seed 5-yr ROI (realized)
1.9%
5-yr annualized return
21%
Win rate (profitable exit)
4.2 : 1
Profit/loss ratio

Anchored on Google Trends keyword "cyclosporiasis" · Auto-generated by deterministic model, not manual due diligence · Narrative prose was generated in Chinese; framework labels are localized.

Executive Summary

Executive Summary

为美国居民提供24/7环孢子虫症AI诊断建议、检测预约与健康追踪服务

全自动环孢子虫症信息与检测指导平台

搜索量激增200%显示公众急需可靠信息;CDC数据显示夏季高发期来临

Seed return at a glance (realized / cash basis): Cumulative ROI of Y1 -69.0%, Y2 -43.6%, Y3 -22.8%, Y4 -5.2%, Y5 9.8%; ~1.9% 5-yr annualized; win rate (profitable exit) ~21.2%; profit/loss ratio ~4.19:1; expected MOIC ~1.10×.
Source Hot Keyword

Source Hot Keyword

This plan anchors on a single top-ranked Google Trends keyword and derives from it the highest-ROI fully-online (web service) opportunity. The table below is the full provenance snapshot of that source keyword (stored with the plan and auditable).

Source keywordcyclosporiasis
Collection rank
Search volume10,000
Growth rate+200%
Trend persistencepersistence: Recurring (2 observations over 2 days)
Commercial intentintent: Informational (6/10)
CategoryHealth
RegionUS
Collected at07/08/2026, 08:16 AM
Source tabletrending_now
Opportunity Selection

Opportunity Selection & Ranking

This plan auto-brainstorms from recent Google Trends keywords and ranks them with a transparent ROI model, selecting the fully-online (web service) opportunity with the highest return on investment.

RankOpportunityROI scoreOne-line positioning
1CycloAlert AI 5.63 为美国居民提供24/7环孢子虫症AI诊断建议、检测预约与健康追踪服务

Supporting trend evidence (sample)

cyclosporiasis · vol 10,000 · +200%
Problem

Problem

美国每年1500+例环孢子虫症,患者难以快速获得专业指导与检测资源

Solution

Solution

AI驱动的症状评估、检测指导与健康监测SaaS平台

AI症状评估器:基于CDC指南的智能问诊

检测中心匹配:自动推荐最近的认证实验室

健康追踪日志:14天症状监测与提醒

知识库订阅:实时疫情警报与预防指南

Market

Market Analysis

TAM: $2.8B(美国数字健康信息服务市场)

SAM: $140M(传染病信息与检测指导细分)

SOM: $7M(5%市场份额目标)

基于IBISWorld 2024报告×5%传染病占比

Product

Product & Service

AI症状评估器:基于CDC指南的智能问诊

检测中心匹配:自动推荐最近的认证实验室

健康追踪日志:14天症状监测与提醒

知识库订阅:实时疫情警报与预防指南

Business Model

Business Model & Unit Economics

基础版 · $9.99/月 · 症状评估+检测指导

专业版 · $19.99/月 · 含健康追踪+优先支持

家庭版 · $29.99/月 · 覆盖5人+旅行警报

CAC $15(Google Ads均值)LTV $180(18月留存×$10 ARPU)

Financial metricYear 1Year 2Year 3
Active users4,16111,55823,115
Paying users108301601
Revenue (¥)¥242,611¥676,166¥1,350,086
Gross profit (¥)¥198,941¥554,456¥1,107,071
Opex (¥)¥630,476¥1,026,428¥1,481,890
EBITDA (¥)¥-431,535¥-471,972¥-374,819

Unit economics: LTV $768 · effective CAC $224 · LTV/CAC 3.42:1 (healthy ≥3:1, credible cap 6:1) · payback 10.53 months · avg lifetime 3 years.

Year-3 indicative exit EV ≈ ¥0 (at 4× SDE/EBITDA, online-asset M&A benchmark).

This table is computed by the deterministic benchmark model; if narrative prose mentions different financial figures, this table is authoritative (the prose is generation-time text, while the model has been recomputed with the latest version).

Seed Returns

Seed Return Analysis

Methodology: 实现口径(现金 cash-on-cash / “拿到钱”)。失败、以及存活但未发生流动性事件的“僵尸”均计 0 实现回报;仅成功退出(并购/二级转让/回购/分红回本)计入收益。

1. Seed-round ROI by year (realized)

Holding periodCumulative ROIAnnualized return
Year 1 -68.99% -68.99%
Year 2 -43.61% -24.91%
Year 3 -22.84% -8.28%
Year 4 -5.21% -1.33%
Year 5 9.76% 1.88%
0% -69%Year 1-44%Year 2-23%Year 3-5%Year 410%Year 5

Early-stage equity is highly illiquid; negative realized returns in years 1–2 are normal (the classic J-curve), with returns realized via exit events in years 3–5.

2. Core investment metrics

21.2%
Win rate: probability of a profitable, cash-realized exit
4.19:1
Profit/loss ratio (avg win / avg loss)
1.10×
Expected MOIC (5-yr, realized)
1.9%
5-yr annualized return

3. 5-year capital outcome breakdown (why "cash realized" ≠ "paper alive")

OutcomeProbabilityRealized return to investor
Failure / liquidation27.1%≈ 0 (loss)
Alive but no liquidity event (paper-alive / zombie)40.3%≈ 0 (not realizable)
Cash exit event occurred (profitable exits 21.2%)32.6%Realized per MOIC distribution

Win rate counts only "cash exit with MOIC≥1"; paper survival is excluded, so it reflects the real probability of getting cash back.

4. Sensitivity analysis

Scenario5-yr ROI5-yr ann.Win rate
Pessimistic -41.6% -10.2% 15.1%
Base 9.8% 1.9% 21.2%
Optimistic 75.7% 11.9% 27.1%

5. Upside scenario vs. paper accounting

If exit succeeds

5.06× multiple; ~50.0% annualized (assuming exit in year 4).

Conditional "profitable exit succeeds" scenario for contrast (not an expected value; occurs with only ~21.2% probability).

Paper accounting (not used)

Year-5 survival rate ≈ 68.0%.

Paper basis: counts companies still alive in year 5 at a marked valuation as "value" — a non-cashable paper figure. Official return figures never use this basis.

Go-To-Market

Go-To-Market (GTM)

SEO内容营销:针对'cyclosporiasis symptoms'等长尾词

Google Ads精准投放:地理定向高发州(德州、佛州)

医疗KOL合作:WebMD、Healthline内容植入

Competition

Competition

WebMD — 我们专注单一疾病,AI响应更精准快速

Teladoc — 纯AI服务成本仅其1/10,无需等待医生

Roadmap

Roadmap

Q1-Q2
  • MVP上线+获得首100付费用户
Q3-Q4
  • 优化AI准确率至95%+扩展至3种疾病
Y2
  • B2B企业健康计划+保险公司合作
Y3+
  • 全美覆盖+国际扩张(加拿大、英国)
Team

Team & Organization

全流程AI自动化,仅保留合规审查人工监督

获客 — Google Ads API + SEO自动优化工具Surfer

交付 — GPT-4医疗版API处理问诊+Mapbox定位检测点

客服 — Intercom AI Agent处理95%咨询

收款 — Stripe自动订阅扣费+发票

运维 — AWS Auto Scaling+CloudWatch自动告警

Risks

Risks & Mitigations

RiskMitigation
FDA政策收紧预留合规预算,聘请医疗法律顾问
AI误判责任购买E&O保险+免责条款+强制就医提示
季节性需求开发其他夏季传染病模块分散风险
The Ask

The Ask

Methodology & Sources

Methodology & Sources

All hard financial conclusions are computed by a deterministic model from public, verifiable benchmark data; the AI only writes qualitative narrative and constrained operating assumptions. Out-of-range assumptions are auto-corrected (see above). Returns always use the cash-realized basis.

  1. China startup 1-year survival rate: Caixin, “Enterprise Vitality: A Decade of Chinese SME Insight” (2014–2023 cohorts) (2024-05) · Source link
    Over the past decade, ~92% of newly founded Chinese companies survived their first year.
  2. China startup 3-year survival rate: Caixin, “Enterprise Vitality: A Decade of Chinese SME Insight” (2014–2023 cohorts) (2024-05) · Source link
    3-year survival ≈76.0% for 2014–2023 cohorts (annual attrition 8.2% / 9.4% / 6.4%).
  3. China startup 5-year survival (interpolated): Interpolated estimate (geometric, between y3 = 0.76 and y10 = 0.503) (2024-05) · Source link
    The report gives no direct 5-year figure; constant-hazard geometric interpolation between years 3 and 10 yields ≈67.5%, explicitly labelled an interpolated estimate.
  4. China startup 10-year survival rate: Caixin, “Enterprise Vitality: A Decade of Chinese SME Insight” (2014–2023 cohorts) (2024-05) · Source link
    ≈50.3% of companies survive to year ten.
  5. Average Chinese SME lifespan: People’s Bank of China report (widely cited by Chinese media) (2019-06) · Source link
    Average Chinese SME lifespan ≈3 years (US ≈8 years, Japan ≈12 years).
  6. Share of VC capital realizing <1x: Correlation Ventures — “Venture Capital, We’re Still Not Normal” (2010s decade (realized)) · Source link
    ≈37% of invested capital realized <1x (a loss); by deal count, roughly half of deals lose money.
  7. Share of VC capital realizing ≥10x: Correlation Ventures (2010s decade (realized)) · Source link
    Less than 4% of invested capital realizes ≥10x (the power-law tail).
  8. VC return power law: Correlation Ventures — “The 80/20 Rule for U.S. Venture? Not Exactly.” (2010s decade) · Source link
    Returns are highly right-skewed; a small number of winners contribute most of the profits.
  9. Exit MOIC distribution (calibrated): Calibration: Correlation Ventures realized-return shape + online-asset M&A multiples (Empire Flippers / FE International / Acquire.com, 2026) (2026) · Source link
    MOIC distribution conditional on a realized cash liquidity event (M&A / secondary / buyback); upside is compressed for small online assets (rarely >25x). Bucket probabilities sum to 1.
  10. Annual exit-realization hazard (assumption): Documented assumption: median VC exits take ~5–8 years; small online assets transact faster via Acquire.com / Empire Flippers / FE International; calibrated so the cumulative 5-year exit probability ≈40% conditional on survival. (2026) · Source link
    Cumulative L(t) = 1-(1-h)^t; h = 0.097 → L(5) ≈ 0.40. Explicitly labelled an assumption and stress-tested in the sensitivity analysis.
  11. Micro-SaaS ARR multiple: CT Acquisitions / Empire Flippers / Acquire.com market observations (2026) · Source link
    Micro-SaaS (<$1M ARR) typically trades at 2.5–4x ARR.
  12. Micro-SaaS SDE multiple: FE International / Empire Flippers (2026) · Source link
    Typically 4–6x seller discretionary earnings (SDE); assets with low owner-dependency fetch the high end.
  13. Trend annualization factor (model assumption): Documented model assumption: trending interest decays in pulses; annual topic interest ≈ 30 peak-day equivalents (2026)
    Google Trends volumes are peak-day buckets; annual topic searches ≈ peak-day volume × 30. Explicitly a disclosed model assumption, bounded by the reach limits below.
  14. Capture share (model assumption): Documented model assumption: a focused niche site captures ~1% of annual topic search interest at maturity (2026)
    Derived conservatively from SERP click-share distributions (~28% at #1, ~7% at #5, <1% on page 2); modulated ±50% by data-driven persistence/intent scores.
  15. Reachable-user bounds (model constraint): Documented model constraint: year-3 reachable users are saturation-compressed into [20k, 600k] (2026)
    Lower bound = minimum viable niche audience; upper bound = realistic single-niche-site capacity ceiling. Applied via a saturating function, not a hard clamp.
  16. Zero-human fixed ops base (model assumption): Documented model assumption: hosting/compliance/model-subscription/monitoring base ramps $60k → $90k → $120k over years 1-3 (2026)
    No payroll (zero-human company); includes outsourced legal/finance and exception-handling budget.
  17. Per-active-user marginal cost (model assumption): Documented model assumption: ~$0.8 per active user per year for inference + infrastructure (2026)
    Estimated for lightweight AI workflows with caching and batching.
  18. USD/CNY exchange rate: Recent approximate CNY-per-USD rate (used for conversion; updated as needed) (2026) · Source link
    Exchange rates fluctuate; converted figures are approximations as of the stated date.
  19. Seed-round equity dilution: Industry norm: a single seed round typically dilutes 10%–20% (2026) · Source link
    Baseline 12%; used to convert enterprise-level exit value into the seed investor’s share.
  20. Early-stage venture discount rate: Early-stage VC required rates of return are typically 30%–60% (high risk premium) (2010s) · Source link
    Used for risk-adjusted discounting; baseline 35%.